Sonnet BioTherapeutics Holdings, Inc. — Form D

Sonnet BioTherapeutics Holdings, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2013-11-20. The offering totals $800K, of which $800K was reported sold. Industry: Restaurants.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Michael D CarrollDirectorCHARLOTTE, NC
Paul J MoskowitzDirectorCHARLOTTE, NC
Eric D LedererExecutive OfficerCHARLOTTE, NC
Michael D PruittExecutive OfficerCHARLOTTE, NC
Keith JohnsonDirectorWilson, WY
Michael PruittDirectorHauppauge, NY
Michael PruittExecutive OfficerHauppauge, NY
Michael CarrollDirectorRichmond, VA
John K CiniExecutive OfficerPrinceton, NJ
Albert K DyrnessDirectorPrinceton, NJ
Nailesh K BhattDirectorPrinceton, NJ
Pankaj MohanDirectorPrinceton, NJ
Pankaj MohanExecutive OfficerPrinceton, NJ
Donald K GriffithDirectorPrinceton, NJ
Susan K DexterExecutive OfficerPrinceton, NJ
Richard K KennyExecutive OfficerPrinceton, NJ
Raghu K RaoDirectorPrinceton, NJ
Jay CrossExecutive OfficerSouth San Francisco, CA
Lori K McNeilDirectorPrinceton, NJ
Keith J JohnsonDirectorCharlotte, NC
Paul MoskowitzDirectorBoston, MA
Paul MoskowitzExecutive OfficerBoston, MA
GREGORY E KRAUTDirectorWESTPORT, CT
Russell J PageDirectorCharlotte, NC
Neil C KieferDirectorCharlotte, NC

Other filings by this issuer (11)

FiledFormOfferingSold
2024-12-23D$3.9M$3.9M
2023-07-17D$2.3M$2.3M
2022-08-19D$2.3M$2.3M
2018-05-16D$1.4M$1.4M
2017-05-11D$6.0M$6.0M
2015-03-18D$1.0M$1.0M
2015-01-16D$1.1M$1.1M
2013-10-22D$2.5M$2.5M
2013-10-15D
2013-08-13D$3.0M$3.0M
2011-11-30D$1.1M$1.1M

More